July/August 2026
July/August 2026 | Pediatrics
Patient Diversity in ROP Trials
A novel analysis reveals the racial and ethnic representation across retinopathy of prematurity clinical trials from 1995 to 2023.
Yannet Daniel, BS; Xiru Lyu, MS; Cagri Besirli, MD, PhD; and Emily Eton, MD
July/August 2026 | Features
IRD Clinical Trial Endpoints: Lessons Learned
Choosing the right outcome measures for inherited retinal disease trials requires matching endpoints to disease biology, therapeutic mechanism, and patient experience.
Melissa Yuan, MD, and Ahmad Al Moujahed, MD, PhD
July/August 2026 | Features
Therapies for IRDs: Moving Beyond Single-Gene Solutions
Emerging gene-agnostic strategies target shared pathways and offer options for IRD patients without mutation-specific therapies.
Aykut Demirkol, MD; Rajvir Solanky; Jayvin Hernandez-Reyes; Ilay Demirkol; and Kuzey Soydas
Popular Articles
March 2026 | Meeting Minutes
ACRC and Macula 2026: A Summary
The annual meeting boasted top-notch clinical and surgical education, honored guests, and comradery.
Justin C. Muste, MD; Collin Richards, MD; Timothy Xu, MD; and Erik Massenzio, MD
May/June 2026 | Features
PBM for AMD: Mechanisms, Evidence, and Clinical Integration
Photobiomodulation shows promise, but long-term data are needed.
Luis Acabá-Berrocal, MD, and Anton Orlin, MD
April 2026 | Surgical Pearls
Extended ILM Peeling for PVR
This technique can help prevent recurrent retinal detachment by completely removing traction and the scaffold for reproliferation.
Taku Wakabayashi, MD, PhD, and Yoshihiro Yonekawa, MD